How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel
- 7 July 2011
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 155 (8), 1877-1883
- https://doi.org/10.1002/ajmg.a.34087
Abstract
For many recessive genetic syndromes, carrier frequencies have been assessed through screening studies in founder populations but remain unclear in heterogeneous populations. One such syndrome is Fanconi Anemia (FA). FA is a model disease in cancer research, yet there are no contemporary data on carrier frequency or prevalence in the general United States (US) population or elsewhere. We inferred carrier frequency from birth incidence using the Hardy–Weinberg law. We estimated prevalence using birth incidence and survival data. We defined “plausible ranges” to incorporate uncertainty about completeness of case ascertainment. We made estimates for the US and Israel using demographic data from the Fanconi Anemia Research Fund and Israeli Fanconi Anemia Registry. In the US, a plausible range for the carrier frequency is 1:156–1:209 [midpoint 1:181]; we estimate that 550–975 persons were living with FA in 2010. For Israel, a plausible range for the carrier frequency is 1:66–1:128 [midpoint 1:93] in line with founder screening studies; we estimate that 40–135 Israelis were living with FA in 2008. The estimated US FA carrier frequency of 1:181 is significantly higher than the historical estimate of 1:300; hence, the gap may be narrower than previously recognized between the US carrier frequency and higher carrier frequencies of around 1:100 in several founder groups including Ashkenazi Jews. Assessment of cancer risks in heterozygous carriers merits further study. Clinical trials in FA will require co‐ordination and innovative design because the number of living US patients is probably less than 1,000. Published 2011 Wiley‐Liss, Inc.Keywords
This publication has 48 references indexed in Scilit:
- Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort studyBritish Journal of Haematology, 2010
- Susceptibility Pathways in Fanconi's Anemia and Breast CancerThe New England Journal of Medicine, 2010
- Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure RegistryHaematologica, 2010
- Rare Variants Create Synthetic Genome-Wide AssociationsPLoS Biology, 2009
- Fanconi anemia and its diagnosisMutation Research - Reviews in Mutation Research, 2009
- Cancer in dyskeratosis congenitaBlood, 2009
- Cancer incidence in relatives of British Fanconi Anaemia patientsBMC Cancer, 2008
- Genetic Heterogeneity among Fanconi Anemia Heterozygotes and Risk of CancerCancer Research, 2007
- Frequency of Fanconi anemia in Brazil and efficacy of screening for the FANCA 3788-3790del mutationBrazilian Journal of Medical and Biological Research, 2005
- Two common founder mutations of the fanconi anemia group g gene FANCG/XRCC9 in the Japanese populationHuman Mutation, 2003